About: Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

article

Attributes	Values
rdf:type	Item
description	article (en) wetenschappelijk artikel (nl) наукова стаття, опублікована в жовтні 1997 (uk) article scientifique publié en 1997 (fr) im Oktober 1997 veröffentlichter wissenschaftlicher Artikel (de)
publication date	wds:Q58972138-9AC9E113-E656-455B-A33D-256E636C854E
publication date	1997-10-01 00:00:00Z (xsd:dateTime)
language of work or name	wds:Q58972138-98475F00-0550-4716-B046-7129055FAC4F
language of work or name	English
cites work	wds:Q58972138-0190AD02-4C49-4782-8825-B7D9BBE25EF9 wds:Q58972138-0960867B-980D-429D-A8EB-133F2DBB1240 wds:Q58972138-16BA2158-6D7A-4375-9E59-85B359F9D27B wds:Q58972138-2582C6E5-7A7C-450C-9CF5-FAB3EA7F88D8 wds:Q58972138-411379BB-8589-456D-85FC-30326F2253B8 wds:Q58972138-582CF645-A103-48FB-B400-C8ECE330DF71 wds:Q58972138-58E665D7-BACC-40A7-BFAA-0EE706A2BE8B wds:Q58972138-5C8D45C7-6723-4F49-B67D-6CEBECB10B72 wds:Q58972138-696DE4C9-C874-42C5-ABA0-784FFE4065BE wds:Q58972138-807C637D-E5EE-430E-B30D-FD1DFEFD2FE2 wds:Q58972138-ABB1D620-04CE-4664-8F1E-443EDB84FD9D wds:Q58972138-B10E59C2-F3CC-4022-AC61-B9B62981F987 wds:Q58972138-B91ACBC7-012E-4CFE-99B0-85ABD386A3AB wds:Q58972138-D0EBFE71-B7F0-45C1-82E3-D1464BD8CF1F wds:Q58972138-D4EE3CE3-DC34-4C53-8E17-FC4DE7F687A8 wds:Q58972138-D7A416CC-8E1C-4BCA-843C-8367DBEE26DE wds:Q58972138-FD858DD3-D4DC-4FEC-99A2-D04121D0B2FF
cites work	Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures. Fracture Intervention Trial Research Group Bisphosphonates: mechanisms of action The effects of 2-year treatment with the aminobisphosphonate alendronate on bone metabolism, bone histomorphometry, and bone strength in ovariectomized nonhuman primates Bisphosphonate action. Alendronate localization in rat bone and effects on osteoclast ultrastructure Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. The Alendronate Phase III Osteoporosis Treatment Study Group. Discontinuous calcitonin treatment of established osteoporosis--effects of withdrawal of treatment Prevention of postmenopausal bone loss by tiludronate Urinary excretion of pyridinoline crosslinks correlates with bone turnover measured on iliac crest biopsy in patients with vertebral osteoporosis Sustained response to intravenous alendronate in postmenopausal osteoporosis Alendronate treatment of the postmenopausal osteoporotic woman: effect of multiple dosages on bone mass and bone remodeling Skeletal metabolism in patients with osteoporosis after discontinuation of long-term treatment with oral pamidronate The therapeutic use of bisphosphonates New bisphosphonates in osteoporosis Bone mass in postmenopausal women after withdrawal of oestrogen/gestagen replacement therapy Long-term effects of a treatment course with oral alendronate of postmenopausal osteoporosis Intermittent treatment with intravenous 4-amino-1-hydroxybutylidene-1,1-bisphosphonate (AHBuBP) in the therapy of postmenopausal osteoporosis Rationale for the use of alendronate in osteoporosis
author name string	wds:Q58972138-1827A550-AFE1-4AA5-A47A-CDEDED31BF2F wds:Q58972138-28B32D5F-F29B-4011-A8A8-A6EA2E6A2CDA wds:Q58972138-368A9101-FBF5-4FA6-A071-453994E045E9 wds:Q58972138-3A5342EB-76C6-4BBC-9BAE-BE0FC0319878 wds:Q58972138-3D780F42-9FAE-45A2-A474-69708188FB46 wds:Q58972138-98FECE97-347C-4CB0-BFFE-378A60E76EC7 wds:Q58972138-B9C666EE-15C5-4E9A-BFFE-B5C5DF81F444 wds:Q58972138-BB72EA99-FDC0-46CE-B7D2-B3949F689CDF wds:Q58972138-C7901277-5001-43A3-BC57-7E41C6C7D63B wds:Q58972138-DAF19231-5DFB-4CC2-8E82-47370146AD99
author name string	N H Bell L Wei F R Singer H K Genant S T Harris A C Santora C H Chesnut J L Stock R A Yood S Pryor-Tillotson
rdfs:label	Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (en) Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (nl)
skos:prefLabel	Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (en) Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (nl)
name	Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (en) Increments in Bone Mineral Density of the Lumbar Spine and Hip and Suppression of Bone Turnover Are Maintained after Discontinuation of Alendronate in Postmenopausal Women (nl)
author	wds:Q58972138-21BC244D-E10E-4C5C-BAF9-9B63A0B9E609 wds:Q58972138-8659E2A6-B6B7-4F32-9464-EBFA9C54ACC7
author	Kristine Ensrud Michael McClung
title	wds:Q58972138-0892E1EE-E056-455F-B312-75A1F0ABC02D
title	Increments in bone mineral density of the lumbar spine and hip and suppression of bone turnover are maintained after discontinuation of alendronate in postmenopausal women (en)
page(s)	wds:Q58972138-E295F4B3-88D0-4466-B76C-9E4DC52F52CC
page(s)	291-297
instance of	wds:Q58972138-1DE249C9-7FD3-4449-B565-3240080253BC
instance of	scholarly article
PubMed ID	wds:Q58972138-3E7F4158-C4DD-4F60-855D-3D74C5EA0C7C
PubMed ID	http://rdf.ncbi.nlm.nih.gov/pubchem/reference/9382121
PubMed ID	9382121
published in	wds:Q58972138-E5FFE445-4385-4BF5-B7FF-3BDA6CFE59A6
published in	American Journal of Medicine
issue	wds:Q58972138-FB086962-3091-42DC-B46E-A05AF75F999E
volume	wds:Q58972138-00BF62B5-EAC4-4194-AE33-FF718B16CE66
issue	4
volume	103
DOI	wds:Q58972138-8FE2403F-45F9-4A2F-967D-31FB1CAD9A3E
DOI	http://dx.doi.org/10.1016/S0002-9343(97)00130-7
DOI	10.1016/S0002-9343(97)00130-7
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q58972138
is cites work of	Fracture risk remains reduced one year after discontinuation of risedronate Cost-effectiveness of alendronate in the treatment of postmenopausal women in 9 European countries--an economic evaluation based on the fracture intervention trial Intervention thresholds for osteoporosis [Postmenopausal osteoporosis. Clinical practice guide] Femoral insufficiency fractures associated with prolonged bisphosphonate therapy Association of low-energy femoral fractures with prolonged bisphosphonate use: a case control study Pharmacokinetics of alendronate

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software